COMPARISON OF TOTAL MEDICAL COST AVOIDANCE WITH THE USAGE OF NEW ORAL ANTICOAGULANTS INSTEAD OF WARFARIN AMONG ATRIAL FIBRILLATION PATIENTS, BASED ON THE ARISTOTLE, RE-LY AND ROCKET-AF TRIALS

✍ Scribed by Steven Deitelzweig; Alpesh Amin; Yonghua Jing; Dinara Makenbaeva; Dinara Makenbaeva; Daniel Wiederkehr; Jay Lin; John Graham

• Book ID: 118582409
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 90 KB
• Volume: 59
• Category: Article
• ISSN: 1558-3597
• DOI: 10.1016/s0735-1097(12)60600-7